✦ LIBER ✦

Temporal evolution of biomarkers and cognitive markers from preclinical to clinical Alzheimer's disease: An Alzheimer's Disease Neuroimaging Initiative (ADNI) study

✍ Scribed by Bertens, Daniela; Scheltens, Philip; Visser, Pieter Jelle

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Validation of Alzheimer’s disease CSF an

✍ Katharina Buerger; Giovanni Frisoni; Olga Uspenskaya; Michael Ewers; Henrik Zett 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 305 KB

Cerebrospinal fluid (CSF) biomarkers in

✍ Judith Siuciak; Eve H. Pickering; Fred Immermann; Max Kuhn; Leslie Shaw; William 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Cerebrospinal fluid (CSF) vs. plasma-bas

✍ William Potter; Eve H. Pickering; Fred Immermann; Max Kuhn; Judith Siuciak; Lesl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Use of an fdg-pet-derived hypometabolic

✍ Napatkamon Ayutyanont; Kewei Chen; Auttawut Roontiva; Adam Fleisher; Jessica Lan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Use of an FDG-PET derived hypometabolic

✍ Ayutyanont, Napatkamon; Chen, Kewei; Roontiva, Auttawut; Fleisher, Adam; Langbau 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Use of biomarkers as endpoint in trials

✍ Bertens, Daniela; Scheltens, Philip; Visser, Pieter Jelle 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 101 KB